Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE...
Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study 2–3 hours of nightly PAP use shows health benefits at 3...
ResMed Announces Leadership Change SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim...
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022 Year-over-year revenue grows 12%, operating profit up...
ResMed Announces Participation in the 24th Annual Macquarie Australia Conference SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed...
ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022 SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX:...
ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum SAN DIEGO, March 17, 2022...
ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day...
ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- ResMed...
ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer Tyagi brings over 25 years’ IT and leadership experience from ADP, American...
People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Supported ALASKA Study Presented at ERS Continued PAP use linked...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지